Institute of Molecular and Industrial Biotechnology, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, 90-537 Lodz, Poland.
Institute of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, 90-924 Lodz, Poland.
Int J Mol Sci. 2022 May 12;23(10):5424. doi: 10.3390/ijms23105424.
Protein prenylation is a post-translational modification controlling the localization, activity, and protein-protein interactions of small GTPases, including the Ras superfamily. This covalent attachment of either a farnesyl (15 carbon) or a geranylgeranyl (20 carbon) isoprenoid group is catalyzed by four prenyltransferases, namely farnesyltransferase (FTase), geranylgeranyltransferase type I (GGTase-I), Rab geranylgeranyltransferase (GGTase-II), and recently discovered geranylgeranyltransferase type III (GGTase-III). Blocking small GTPase activity, namely inhibiting prenyltransferases, has been proposed as a potential disease treatment method. Inhibitors of prenyltransferase have resulted in substantial therapeutic benefits in various diseases, such as cancer, neurological disorders, and viral and parasitic infections. In this review, we overview the structure of FTase, GGTase-I, GGTase-II, and GGTase-III and summarize the current status of research on their inhibitors.
蛋白质的类异戊二烯化是一种翻译后修饰,可控制包括 Ras 超家族在内的小 GTP 酶的定位、活性和蛋白-蛋白相互作用。这种将法呢基(15 个碳)或香叶基(20 个碳)异戊二烯基团共价连接的过程是由四种类异戊二烯转移酶催化的,即法尼基转移酶(FTase)、香叶基转移酶 I 型(GGTase-I)、Rab 香叶基转移酶(GGTase-II)和最近发现的香叶基转移酶 III 型(GGTase-III)。阻断小 GTP 酶的活性,即抑制类异戊二烯转移酶,已被提议作为一种潜在的疾病治疗方法。类异戊二烯转移酶抑制剂已在各种疾病(如癌症、神经紊乱以及病毒和寄生虫感染)中产生了显著的治疗益处。在这篇综述中,我们概述了 FTase、GGTase-I、GGTase-II 和 GGTase-III 的结构,并总结了它们抑制剂的研究现状。